Company Filing History:
5 out of 26 
4 out of 110 
1 out of 1 Years Active: 2018-2022
Title: Shigemitsu Takeda: Innovator in Anticancer Research
Introduction
Shigemitsu Takeda is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anticancer agents. With a total of six patents to his name, Takeda's work is recognized for its potential impact on cancer treatment.
Latest Patents
Among his latest patents, Takeda has developed an anticancer agent that addresses the need for effective prodrug compounds of naphthofuran compounds. This invention provides a compound represented by a specific formula, which may include pharmaceutically acceptable salts. Additionally, he has created a novel cyclin-dependent kinase 8 and/or 19 inhibitor, which serves as an anti-cancer agent. This invention also includes a compound represented by a defined formula, aimed at preventing and treating cancer.
Career Highlights
Throughout his career, Shigemitsu Takeda has worked with notable companies such as Kyoto Pharmaceutical Industries, Ltd. and Sumitomo Dainippon Pharma Co., Ltd. His experience in these organizations has allowed him to advance his research and contribute to the development of innovative cancer therapies.
Collaborations
Takeda has collaborated with esteemed colleagues, including Yoshimichi Shoji and Yoshinobu Yoshimura. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.
Conclusion
Shigemitsu Takeda's work in the field of anticancer research exemplifies the importance of innovation in medicine. His patents and collaborations highlight his commitment to improving cancer treatment options. Through his efforts, Takeda continues to make a significant impact in the pharmaceutical industry.